Blue Jet Healthcare Limited (NSE:BLUEJET)
India · Delayed Price · Currency is INR 446.40
-6.10 (-1.35%)
Jun 3, 2026, 12:41 PM IST
Blue Jet Healthcare Revenue
In the fiscal year ending March 31, 2026, Blue Jet Healthcare had annual revenue of 9.47B INR, down -8.03%. Blue Jet Healthcare had revenue of 2.35B in the quarter ending March 31, 2026, a decrease of -31.07%.
Revenue
9.47B
Revenue Growth
-8.03%
P/S Ratio
8.29
Revenue / Employee
48.33M
Employees
196
Market Cap
78.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.47B | -826.64M | -8.03% |
| Mar 31, 2025 | 10.30B | 3.18B | 44.74% |
| Mar 31, 2024 | 7.12B | -93.84M | -1.30% |
| Mar 31, 2023 | 7.21B | 375.13M | 5.49% |
| Mar 31, 2022 | 6.83B | 1.85B | 36.99% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biocon | 169.27B |
| Dishman Carbogen Amcis | 29.32B |
| Anthem Biosciences | 21.24B |
| OneSource Specialty Pharma | 14.37B |
| Concord Biotech | 11.07B |
| Supriya Lifescience | 8.28B |
| Panacea Biotec | 6.57B |
| Zota Health Care | 5.39B |